Edith Bigot‐Corbel
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 9
Edith Bigot‐Corbel
48 papers receiving 569 citations
Peers
Comparison fields: 5 of 89
- Hematology 132
- Genetics 106
- Nephrology 48
- Endocrinology, Diabetes and Metabolism 75
- Immunology 81
Countries citing papers authored by Edith Bigot‐Corbel
This map shows the geographic impact of Edith Bigot‐Corbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Bigot‐Corbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Bigot‐Corbel more than expected).
Fields of papers citing papers by Edith Bigot‐Corbel
This network shows the impact of papers produced by Edith Bigot‐Corbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Bigot‐Corbel. The network helps show where Edith Bigot‐Corbel may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith Bigot‐Corbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 14 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 32 | |
| 18 | 2016 | 14 | |
| 19 | 2015 | 6 | |
| 20 | 2012 | 16 |
About Edith Bigot‐Corbel
Edith Bigot‐Corbel is a scholar working on Nephrology, Hematology, Genetics, Hepatology and Clinical Biochemistry, having authored 54 papers that have together received 575 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Hepatitis C virus research (5 papers), Lipoproteins and Cardiovascular Health (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Galectins and Cancer Biology (4 papers). The work is most often cited by research in Hematology (132 citations), Genetics (106 citations), Nephrology (48 citations), Endocrinology, Diabetes and Metabolism (75 citations) and Immunology (81 citations). Edith Bigot‐Corbel has collaborated with scholars based in France, Spain and Canada. Frequent co-authors include Sylvie Hermouet, Betty Gardie, Bertrand Cariou, Samy Hadjadj, Matthieu Pichelin, Jean Harb, Sophie Allain‐Maillet, Anne Tallet, Matthieu Wargny and Éric Piver. Their work appears in journals such as Frontiers in Immunology, Blood, Cancers, Clinical Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.